Furthermore, inflammatory mediators such as interleukin-1 β (IL-1β), monocyte chemotactic protein-1, and matrix metalloprotease-9 exhibit significant upregulation in the brains of AD patients [6,7]. The gene discussed is IL1B; the disease is Alzheimer disease.